Invariant Natural Killer T cells control positively and negatively the development of hepatocellular carcinoma
Preprint
Abstract
The liver routinely encounters antigens from the gut, triggering pro- inflammatory responses. Unresolved inflammation can lead to liver damage, steatosis, fibrosis, cirrhosis, and eventually hepatocellular carcinoma (HCC). HCC is influenced by various immune cells, including invariant natural killer T (iNKT) cells, which exhibit both innate and adaptive immunity traits. Here, we examined iNKT cell dynamics in a diethyl-nitrosamine (DEN)-induced HCC mouse model. We observed a significant reduction in iNKT cell numbers in HCC livers due to apoptosis and impaired cytokine production. CD1d -deficient mice, which lack iNKT cells, displayed delayed tumor initiation and lower tumor and foci number. However, these tumors were larger in size and characterized by enhanced proliferation and immunosuppression. Interestingly, adoptive transfer of healthy iNKT cells post-tumor establishment reduced tumor burden, highlighting their potential therapeutic role. Our findings suggest that iNKT cells contribute to early HCC development, while in later stages they help to control tumor growth, thus underscoring their complex role in liver carcinogenesis. Further understanding of iNKT cell functions may inform novel immunotherapeutic strategies for HCC management.Keywords
This publication has 63 references indexed in Scilit:
- Regulatory T cell: a double-edged sword from metabolic-dysfunction-associated steatohepatitis to hepatocellular carcinomaEBioMedicine, 2024
- Adoptive Transfer of Autologous Invariant Natural Killer T Cells as Immunotherapy for Advanced Hepatocellular Carcinoma: A Phase I Clinical TrialThe Oncologist, 2021
- Role of regulatory T cells and checkpoint inhibition in hepatocellular carcinomaCancer Immunology, Immunotherapy, 2019
- The liverCurrent Biology, 2017
- Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell SequencingCell, 2017
- A novel “humanized mouse” model for autoimmune hepatitis and the association of gut microbiota with liver inflammationHepatology, 2015
- Metabolic Activation of Intrahepatic CD8+ T Cells and NKT Cells Causes Nonalcoholic Steatohepatitis and Liver Cancer via Cross-Talk with HepatocytesCancer Cell, 2014
- Anti-tumor potential of type-I NKT cells against CD1d-positive and CD1d-negative tumors in humansClinical Immunology, 2011
- Suppression of hepatocellular carcinoma by transplantation of ex‐vivo immune‐modulated NKT lymphocytesInternational Journal of Cancer, 2005
- CD1d‐mediated stimulation of natural killer T cells selectively activates hepatic natural killer cells to eliminate experimentally disseminated hepatoma cells in murine liverInternational Journal of Cancer, 2003